Episodes

  • Miracles of Mistletoe Therapy (Part 2): Bridging Ancient Wisdom and Modern Cancer Treatment

    Miracles of Mistletoe Therapy (Part 2): Bridging Ancient Wisdom and Modern Cancer Treatment
    Dec 20 2024
    In this episode of The Prescribed Podcast, Dr. Nathan Goodyear and Dr. Nasha Winters explore mistletoe therapy, an innovative advancement in integrative oncology. This discussion examines mistletoe’s historical use, its scientifically validated mechanisms, and its future potential as a powerful adjunctive treatment in cancer care. The episode also addresses the regulatory and cultural challenges that have limited its adoption in North America compared to its widespread acceptance in European oncology centers. Mistletoe therapy has been used for centuries in traditional medicine and offers significant benefits when integrated into conventional cancer treatments. With its role in immune modulation, reduction of chemotherapy side effects, and improvement in quality of life, mistletoe is becoming a vital topic for healthcare providers and patients seeking holistic cancer care. Take Action If find yourself interested in learning more check out https://pre-scribed.com/ and learn more about Dr. Nasha Winters at https://www.drnasha.com/ Key Topics Discussed 1. History of Mistletoe in Medicine Ancient Roots: Used by Druids in traditional remedies, mistletoe has been revered for centuries. Oncology Applications: The integration of mistletoe into cancer care began in the 20th century with Rudolf Steiner and Ita Wegman. Research Evolution: Mistletoe therapy bridges traditional wisdom and modern science. 2. Scientific Insights Mechanisms of Action: Mistletoe supports immune modulation, induces apoptosis, and has cytotoxic effects on cancer cells. Key Components: Compounds like lectins and viscotoxins play essential roles in its therapeutic action. Research Findings: Clinical studies demonstrate mistletoe’s ability to improve quality of life, reduce side effects, and enhance immune function. 3. Clinical Applications Improved Patient Outcomes: Evidence supports mistletoe’s efficacy in enhancing patient tolerance to treatments. Holistic Integration: Mistletoe therapy complements conventional treatments, providing comprehensive care. 4. Challenges in Adoption Regulatory Barriers: Accepted in Germany and Switzerland, mistletoe faces hurdles in the U.S. Awareness Gap: Many providers and patients remain unaware of mistletoe’s therapeutic potential. Research Limitations: Standardization and methodology issues contribute to skepticism. 5. Future Directions Personalized Medicine: Mistletoe is being integrated into precision cancer care. Innovative Delivery Methods: Intratumoral and intravenous applications enhance effectiveness. Expanded Research: Ongoing trials are solidifying mistletoe’s role in oncology. Expanding Access to Mistletoe Efforts are underway to increase global awareness and access to mistletoe therapy. Educational initiatives aim to inform healthcare providers, patients, and policymakers about its potential benefits. Greater international collaboration is crucial to overcoming regulatory barriers and improving patient care worldwide. Why This Discussion Matters Mistletoe therapy represents a paradigm shift in cancer care, blending traditional medicinal knowledge with rigorous modern research. Proven safe and effective in European oncology centers, mistletoe remains underutilized in North America. This episode provides insights for healthcare professionals and patients, empowering them with knowledge to explore mistletoe therapy as part of comprehensive cancer treatment strategies. Key Takeaways for Patients and Practitioners 1. Efficacy: Mistletoe therapy is supported by extensive research demonstrating its safety and effectiveness. 2. Quality of Life: Patients report significant improvements in fatigue, nausea, and emotional well-being. 3. Integrative Oncology: Combining conventional and complementary therapies provides a holistic cancer care approach. References and Sources Wode K, et al. "Mistletoe Extract in Patients With Advanced Pancreatic Cancer: A Double-Blind, Randomized, Placebo-Controlled Trial (MISTRAL)." Dtsch Arztebl Int., 2024. Link. Paller CJ, et al. "Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer." Cancer Res Commun., 2023. Link. Hohneck AL, et al. "Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia." Cancers., 2023. Link. Timestamps 00:00 Introduction to Mistletoe and Integrative Oncology 01:56 The Historical Context of Mistletoe in Medicine 04:12 Mistletoe's Unique Characteristics and Uses 10:13 The Philosophy Behind Mistletoe Therapy 12:10 The Evolution of Mistletoe as a Cancer Treatment 18:18 The Global Perspective on Mistletoe Therapy 24:46 Challenges in Mistletoe Research and Acceptance 26:39 Understanding Mistletoe in Cancer Treatment 39:11 The Future of Mistletoe Therapy in the US 46:31 Mistletoe: A Paradigm Shift in Cancer Care
    Show More Show Less
    53 mins
  • Miracles of Mistletoe Therapy (Part 1): Is This Christmas Plant the Secret to Beating Cancer?

    Miracles of Mistletoe Therapy (Part 1): Is This Christmas Plant the Secret to Beating Cancer?
    Dec 20 2024
    Mistletoe has long been associated with the holiday season, but few people know its rich history and powerful potential in integrative oncology. In this episode of Prescribed by Dr. Nathan Goodyear, we explore the science and practical applications of mistletoe therapy in cancer treatment. Join Dr. Goodyear and Dr. Miranda LaBant as they discuss the research, mechanisms of action, and innovative ways mistletoe is being used to transform patient outcomes in oncology. Take Action Learn More from Dr. LaBant at https://drmirandalabant.com/ Find more cancer care resources at https://pre-scribed.com/ Watch Part 2 Now! The Medicinal Potential of Mistletoe Mistletoe, a semi-parasitic plant, has been used for centuries in folk medicine for its therapeutic properties. In modern integrative oncology, mistletoe therapy has gained recognition for its immune-modulating, cytotoxic, and anti-inflammatory effects. With over 7,000 research publications, mistletoe is one of the most well-studied natural remedies in cancer care. What You’ll Learn in This Episode: 1. Historical and Cultural Roots: Mistletoe has been documented in folklore and traditional medicine for thousands of years, with its earliest references dating back to the Druids. It has since evolved from a folk remedy into a highly researched therapeutic agent in integrative oncology. 2. Types of Mistletoe: While there are over 1,200 species of mistletoe, only a few are used in medicine. European mistletoe (Viscum album), American mistletoe (Phoradendron leucarpum), and dwarf mistletoe (Arceuthobium spp.) have been studied extensively for their medicinal properties. In clinical practice, Viscum album is the most commonly used species for cancer therapy. 3. Extraction Methods: The method of extraction significantly impacts the effectiveness of mistletoe therapy. The four main extraction techniques are: Iskador Method: A fermented extraction process that enhances bioavailability. Abnoba Method: A cold extraction that preserves sensitive compounds like lectins and viscotoxins. Viscum Method: An aqueous extraction focusing on purity. Helixor Method: A cold maceration process that maintains the balance of bioactive components. 4. Mechanisms of Action: Immune Modulation: Mistletoe stimulates the immune system by increasing the activity and number of dendritic cells, natural killer cells, and lymphocytes. It also boosts cytokine production, enhancing the body’s natural defenses against cancer. Cytotoxic Effects: Mistletoe induces apoptosis (programmed cell death) in cancer cells and inhibits tumor growth by stabilizing DNA and reducing inflammation. Tumor Inhibition: By targeting pathways like COX-2 and VEGF, mistletoe suppresses cancer metastasis and angiogenesis (the formation of new blood vessels that feed tumors). 5. Clinical Applications: Subcutaneous Injections: A common delivery method that provides chronic immune stimulation. Patients can be trained to administer these injections at home. Intravenous Therapy: Offers a more intensive systemic approach, often used as an adjunct to chemotherapy. Intratumoral Therapy: Directly targets tumors, enhancing local immune responses and reducing systemic side effects. Intravesical Therapy: Used in bladder cancer treatment, demonstrating success in reducing recurrence rates. 6. Research Highlights: A German study in 2023 showed that mistletoe therapy combined with chemotherapy and hyperthermia doubled the overall survival rate in pancreatic cancer patients compared to chemotherapy alone. A Phase I trial at Johns Hopkins University in 2021 confirmed the safety of intravenous mistletoe, showing improved quality of life and disease control in advanced cancer patients. Timestamps 00:00 Introduction to Integrative Oncology and Mistletoe 03:06 The Medicinal Value of Mistletoe 05:57 Understanding Mistletoe as a Folk Remedy 09:11 Types of Mistletoe and Their Applications 12:01 Mistletoe in Clinical Practice and Research 15:12 The Role of Mistletoe in Cancer Treatment 17:49 Immunotherapy and Mistletoe's Mechanisms 20:45 Research Findings on Mistletoe and Cancer 23:48 Complexities of Mistletoe Therapy 25:23 Understanding Mistletoe Extraction Methods 30:36 Mechanisms of Action in Mistletoe Therapy 35:51 Precision Cancer Care and Mistletoe 39:08 Intratumoral Approaches to Mistletoe Therapy 47:31 Future Directions in Mistletoe Research Sources Cited in This Episode: Wode K, et al. “Mistletoe Extract in Patients With Advanced Pancreatic Cancer: A Double-Blind, Randomized, Placebo-Controlled Trial.” Dtsch Arztebl Int. 2024 May 31;121(11):347-354. DOI:10.3238/arztebl.m2024.0080 Paller CJ, et al. “Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.” Cancer Res Commun. 2023 Feb 28;3(2):338-346. DOI:10.1158/2767-9764.CRC-23-0002 Wode K, et al. “Mistletoe Therapy and Its Impact on Immune Modulation and Quality of Life in Cancer Patients.” Integrative Cancer Therapies. 2023.
    Show More Show Less
    51 mins
  • Vitamin C Infectious Disease Secrets: Immune Boost & Cancer Prevention | Dr. Nathan Goodyear -Part 2

    Vitamin C Infectious Disease Secrets: Immune Boost & Cancer Prevention | Dr. Nathan Goodyear -Part 2
    Dec 20 2024
    Welcome to another episode of Prescribed by Dr. Nathan Goodyear, where we explore cutting-edge medical science through the lens of integrative oncology and holistic health. In this episode, we dive deep into Vitamin C—a powerhouse of health benefits that’s been transforming medicine for nearly a century. Discover how Vitamin C combats infectious diseases, boosts the immune system, and enhances cancer treatment. What You'll Learn in This Episode Dr. Goodyear unpacks the historical significance and contemporary breakthroughs surrounding Vitamin C: Boosting Immune Defense: Learn how high-dose IV Vitamin C enhances immune function, prevents cytokine storms, and fights systemic infections (Jungeblut, 1935). Inhibiting Viral Activity: Explore Vitamin C’s mechanisms in combating viral replication and assembly, including its effectiveness against HIV (Harakeh, 1990), COVID-19 (Miranda-Massari, 2021), and herpes zoster (Ali & Nader, 2020). Historical and Modern Applications: Trace Vitamin C’s journey from early studies in the 1930s to modern uses in treating polio, sepsis, and cancer (Jungeblut, 1937). Precision Medicine: Discover the role of Vitamin C in multiomics, including genomics, metabolomics, and microbiomics, and how it tailors treatments to individual patient needs (Gonzalez et al., 2020). Infectious Diseases and Cancer: Understand the critical link between infections caused by viruses, bacteria, and parasites and their role in cancer development (Vilchèze, 2013). Key Takeaways A Century of Evidence: The first study on Vitamin C demonstrated its ability to inactivate the polio virus (Jungeblut, 1935). Since then, it’s been studied extensively for its antiviral and antibacterial properties. High-Dose IV Therapy: Achieving millimolar plasma levels of Vitamin C can significantly enhance recovery from acute viral infections like the flu and coronavirus (Rozga et al., 2020). Cytotoxic Effects: Vitamin C targets pathogens and cancer cells while protecting healthy cells from oxidative damage (Klenner, 1951). Bacteria and Parasites: Vitamin C shows promise in treating bacterial infections like tuberculosis (Vilchèze et al., 2018) and parasitic diseases such as malaria (Shi et al., 2021). The Vitamin C-Cancer Connection Did you know that up to 25% of cancers are linked to infectious diseases? Dr. Goodyear explains how Vitamin C disrupts this connection by: Enhancing immune system functionality to fight cancer-causing viruses like Epstein-Barr virus (Mikirova & Hunninghake, 2014). Reducing inflammation and oxidative stress that contribute to tumor growth (Hess et al., 2022). Acting as a powerful adjunct to conventional therapies like chemotherapy and radiation (Holford et al., 2020). Vitamin C’s role in precision medicine offers hope for targeted treatments that optimize patient outcomes, making it an indispensable tool in the fight against cancer and chronic diseases. Why This Matters Now During the COVID-19 pandemic, natural therapies like Vitamin C were often dismissed despite mounting evidence supporting their efficacy. Dr. Goodyear highlights how Vitamin C: Prevented cytokine storms in COVID-19 patients (Boretti & Banik, 2020). Improved survival rates and reduced hospital stays when used in high doses (Zhang et al., 2020). Played a critical role in mitigating long-term complications of viral infections (Vollbracht & Kraft, 2022). As the global medical community faces a trust crisis, it’s essential to revisit time-tested therapies like Vitamin C that are safe, cost-effective, and evidence-based. Supporting Studies & References This episode features insights from peer-reviewed research and historical studies, including: 1935 Jungeblut Study: Vitamin C inactivates polio virus (Jungeblut, 1935). 2020 Gonzalez et al.: High-dose Vitamin C prevents respiratory infections and cytokine storms (Gonzalez et al., 2020). 2021 Miranda-Massari Study: Vitamin C’s impact on COVID-19 outcomes (Miranda-Massari et al., 2021). For a full list of references, visit Pre-Scribed.com. Chapters 0:00 - Introduction: Vitamin C and Integrative Oncology 6:10 - Mechanisms of Vitamin C Against Viral Infections 12:00 - Vitamin C’s Role in HIV and Immune Defense 18:55 - High-Dose Vitamin C for Influenza and Common Cold 24:52 - Breakthroughs in COVID-19 Treatment with Vitamin C 33:58 - Historical Studies on Vitamin C 38:09 - Bacterial and Parasitic Infections: Vitamin C’s Role 40:58 - Cancer Prevention and the Infectious Disease Connection 50:23 - Conclusion: The Future of Vitamin C in Precision Medicine DON'T FORGET TO: Like and Share: Help spread life-changing knowledge to others who could benefit. Subscribe: Stay updated on groundbreaking topics in integrative oncology and holistic medicine. Let’s redefine the future of medicine—together. #VitaminC #IntegrativeOncology #ImmuneBoost #CancerTreatment #IVTherapy #COVID19Treatment #HolisticHealth #PrecisionMedicine #DrNathanGoodyear #HealthInnovation
    Show More Show Less
    58 mins
  • Direct Tumor Targeting: How Intratumoral Immunotherapy is Redefining Cancer Treatment & Remission

    Direct Tumor Targeting: How Intratumoral Immunotherapy is Redefining Cancer Treatment & Remission
    Dec 20 2024

    Intramural immunotherapy is reshaping how cancer is treated by offering a targeted, effective, and less toxic alternative to traditional therapies. By focusing on directly treating tumors while activating the body’s immune system to fight cancer systemically, this innovative approach provides new hope for patients. It moves away from high-dose systemic treatments and their often debilitating side effects, representing a groundbreaking shift in oncology.

    What is Intratumoral Immunotherapy? Intratumoral immunotherapy is a next-generation cancer treatment designed to directly inject therapeutic agents into tumors. This method avoids many of the pitfalls of systemic treatments by enhancing precision, minimizing side effects, and triggering a localized immune response that extends systemically. It capitalizes on the abscopal effect, where treating a single tumor can stimulate the immune system to attack cancer elsewhere in the body.

    Key Features of Intratumoral Immunotherapy:

    Targeted Precision: Advanced imaging technologies, such as CT and ultrasound, guide injections to ensure accuracy and effectiveness.

    Combination Strategies: By utilizing a mix of therapies, including cytokines, monoclonal antibodies, oncolytic viruses, and ablation techniques like pulsed electric fields (PEF), this approach delivers powerful, synergistic effects.

    Systemic Benefits: Localized treatments stimulate the immune system to attack cancer throughout the body.

    Lower Toxicity: This method avoids many of the harmful side effects of traditional treatments by focusing on the tumor.

    Improved Quality of Life: Patients often experience less fatigue and maintain a higher level of health during treatment.

    Why This Paradigm Shift Matters Traditional cancer treatments, such as chemotherapy and systemic immunotherapy, rely on high doses to saturate the body with drugs in the hope they will reach the tumor. While these treatments can work, they often harm healthy tissues, suppress the immune system, and leave patients with a diminished quality of life. Intratumoral immunotherapy takes a different approach, delivering treatment directly to the tumor to enhance efficacy while minimizing harm.

    Benefits of Intratumoral Immunotherapy

    1. Localized Therapy: Focused treatment targets the tumor directly, sparing healthy tissues.

    2. The Abscopal Effect: Localized treatment triggers systemic immune responses, leading to the destruction of cancer cells elsewhere in the body.

    3. Combination Therapies: Utilizing multiple therapeutic agents ensures a comprehensive attack on cancer from different angles.

    4. Patient-Centered Outcomes: Patients report higher energy levels, better health, and fewer side effects during and after treatment.

    5. Future-Ready Care: This approach aligns with the latest advancements in precision medicine and integrative oncology.

    Why This Approach is the Future of Cancer Care The response rates for systemic immunotherapy often range from 12-15%, leaving many patients without significant benefit. Intratumoral immunotherapy, on the other hand, is showing promise in improving outcomes, not only extending life but enhancing the quality of that life.

    Timestamps 00:00 Introduction to Integrative Oncology and Holistic Healing 03:19 The Paradigm Shift in Cancer Treatment 12:10 Intratumoral Immunotherapy: A New Approach 21:23 Precision Targeting in Cancer Treatment 30:22 Quality of Life and Patient Empowerment 38:01 Future Innovations in Cancer Care

    Who Should Watch This Video? This video is essential for anyone seeking to understand the future of cancer care:

    Patients: Discover how this treatment could transform your experience with cancer care.

    Physicians: Learn about the science behind this innovative approach and how it’s reshaping oncology.

    Researchers and Students: Gain insights into the cutting-edge advancements in immunotherapy and precision medicine.

    How to Take the Next Step Intratumoral immunotherapy isn’t just an idea for the future—it’s available now. To explore how this revolutionary approach can benefit you or a loved one, visit WilliamsCancerInstitute.com. Learn about the science, see the success stories, and discover how this treatment could change the course of cancer care.

    References Sheth RA et al., Radiology (2024): "Intratumoral Injection of Immunotherapeutics: State of the Art and Future Directions."

    Marabelle et al., Clinical Cancer Research (2023): "Intratumoral Immunization: A New Paradigm for Cancer Therapy."

    Zhang et al., Journal of Hematology & Oncology (2023): "Reshaping the Systemic Tumor Immune Environment."

    Regmi et al., Journal of Experimental & Clinical Cancer Research (2024): "From Glioma Gloom to Immune Bloom: Unveiling Novel Immunotherapeutic Paradigms."
    Show More Show Less
    39 mins
  • Vitamin C Part 1 - Stacking with Chemotherapy: Doubling Survival in Pancreatic Cancer | Dr. Goodyear

    Vitamin C Part 1 - Stacking with Chemotherapy: Doubling Survival in Pancreatic Cancer | Dr. Goodyear
    Dec 20 2024
    "Doubling Survival in Pancreatic Cancer: The Power of High-Dose Vitamin C and Chemotherapy" In this episode of Prescribed by Dr. Nathan Goodyear, we reveal the transformative role of high-dose pharmacological vitamin C in metastatic pancreatic cancer. A pivotal study published in Redux Biology (October 2024) demonstrates how combining vitamin C with chemotherapy can double survival rates and improve the quality of life for patients facing one of the most aggressive cancers. Critical Findings: "Overall survival doubled to 16 months with vitamin C." "Vitamin C disrupts cancer metabolism while protecting healthy cells." "Chemotherapy combined with vitamin C improved patient quality of life and treatment tolerance." Study Overview: This randomized Phase II clinical trial involved 34 patients with Stage IV metastatic pancreatic cancer, split into two groups: 1. Control Group: Standard chemotherapy (gemcitabine and nab-paclitaxel). 2. Intervention Group: Chemotherapy plus high-dose IV vitamin C (75 grams, thrice weekly). Key Results: Overall Survival (OS): Control group: 8 months. Intervention group: 16 months (a 100% increase). Progression-Free Survival (PFS): Control group: 4 months. Intervention group: 6 months. Patients in the vitamin C group reported fewer chemotherapy-related side effects, including fatigue and nausea, and better treatment tolerance. Vitamin C: The Trinity Effect Dr. Goodyear introduces the Trinity Effect, a hallmark of vitamin C in cancer care: 1. Targeting: Generates reactive oxygen species (ROS) in cancer cells, causing oxidative stress and cell death. 2. Protecting: Antioxidant properties protect healthy tissues from chemotherapy’s damage. 3. Healing: Supports immune function and cellular repair, improving overall health during treatment. Mechanisms of Action: Selective Cytotoxicity: High-dose ascorbate generates hydrogen peroxide (H2O2) in tumor microenvironments. Cancer cells, with reduced catalase levels, cannot neutralize H2O2, leading to DNA damage and apoptosis. Energy Crisis: Vitamin C depletes ATP and NADH in cancer cells, disrupting their metabolism and triggering cell death. Synergy with Chemotherapy: Enhances chemotherapy’s effects by amplifying DNA damage and sensitizing cancer cells. Implications for Pancreatic Cancer: Pancreatic cancer is one of the deadliest cancers, with five-year survival rates under 10%. This study highlights how pharmacological vitamin C improves survival and quality of life: Enhanced Tumor Control: Vitamin C slows tumor progression and amplifies chemotherapy’s effects. Reduced Side Effects: Patients experience less nausea and fatigue, improving adherence to treatment and outcomes. Clinical Significance of Catalase: The role of catalase, a key detox enzyme, is central to vitamin C’s selective targeting: Normal Cells: High catalase levels allow healthy tissues to neutralize H2O2 and avoid oxidative stress. Cancer Cells: Low catalase activity makes cancer cells susceptible to H2O2-induced damage. This differential targeting ensures vitamin C harms cancer cells while sparing healthy tissues, making it a cornerstone of integrative therapy. Study-Supported Insights: 1. Programmed Cell Death: Vitamin C triggers apoptosis, necroptosis, and ferroptosis, effectively disrupting tumor growth. 2. Tumor Microenvironment: Reduces stromal barriers and hypoxia-inducible factor-1α (HIF-1α), improving drug delivery and anti-tumor immunity. 3. Dosing Precision: Plasma levels of vitamin C were monitored to ensure therapeutic concentrations exceeding 20 mM (350 mg/dL), optimizing pro-oxidant effects on cancer cells. Call to Action for Patients: Dr. Goodyear stresses patient empowerment in advancing integrative cancer care. By understanding evidence-based therapies like vitamin C, patients can advocate for personalized treatments and drive innovation in medicine. What You Can Do: 1. Educate Yourself: Visit Pre-scribe.com for show notes, references, and resources. 2. Share the Knowledge: Share this episode with loved ones affected by pancreatic cancer. 3. Engage with Us: Subscribe to the Prescribed Podcast for more breakthroughs in integrative oncology. Key Chapters: 00:00 - Introduction: Vitamin C and Pancreatic Cancer Awareness 01:00 - Vitamin C is the Flagship of Integrative Oncology 09:07 - Clinical Study Results: Doubling Survival Rates 22:15 - Mechanisms: Targeting Cancer and Protecting Healthy Cells 29:52 - Conclusion and Patient Advocacy References: Bodeker KL et al. A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Redox Biol. 2024 Nov;77:103375. Shojaei-Zarghani S et al. Theanine and cancer: A systematic review. Phytother Res. 2021;35(9):4782-4794. External Articls & Sources: https://www.foxnews.com/person/s/ange... https://www.foxnews.com/health/pancre...
    Show More Show Less
    35 mins
  • The True Cost of IV Vitamin C in Your Cancer Care: Transforming Treatment with Integrative Medicine

    The True Cost of IV Vitamin C in Your Cancer Care: Transforming Treatment with Integrative Medicine
    Dec 20 2024
    What is the cost of not incorporating IV vitamin C into your cancer care? In this illuminating episode, Dr. Nathan Goodyear unpacks the critical role of high-dose IV vitamin C as a cornerstone of integrative medicine, particularly in cancer treatment. From its origins in groundbreaking research by Linus Pauling to the cutting-edge advancements in 2024, this conversation dives deep into the science, practical applications, and misconceptions surrounding this revolutionary therapy. Discover how IV vitamin C delivers direct cytotoxic effects on cancer cells, enhances quality of life, and reduces the side effects of conventional therapies like chemotherapy and radiation. Dr. Goodyear breaks down the importance of dose, duration, and frequency to maximize therapeutic outcomes, challenging the practices of “drip clinics” that prioritize turnover over patient care. Explore the mechanisms of action—energy crisis, redox crisis, and detoxification crisis—that make high-dose IV vitamin C a game-changer in the fight against cancer. Learn why this therapy is misunderstood by many in conventional medicine and how recent clinical trials, like a groundbreaking phase II pancreatic cancer study, are opening doors to its wider acceptance. Key Topics Covered: = The history of IV vitamin C and its adoption in cancer care. = The debate: Why IV vitamin C remains a point of contention. = The science behind pharmacokinetics and pharmacodynamics of vitamin C. = How IV vitamin C induces an energy crisis and disrupts cancer cell metabolism. = The synergy of IV vitamin C with chemotherapy and immune checkpoint inhibitors. = The critical importance of dose, duration, and frequency for therapeutic success. = Why the true cost is not monetary but in missed opportunities for better patient outcomes. Takeaways: IV vitamin C has direct cytotoxic effects on cancer cells and improves quality of life. Proper dosing (e.g., 1.5 grams per kilogram) ensures therapeutic plasma levels. Frequency matters: Optimal outcomes require dosing every 48 hours, 3x weekly. High-dose IV vitamin C complements conventional treatments like chemotherapy. Clinics must prioritize patient care over rapid chair turnover. Chapters: 00:00 - The Cost of IV Vitamin C in Cancer Care 02:50 - High-Dose IV Vitamin C: Understanding the Basics 05:58 - Mechanisms of Action: Energy, Redox, and Detox Crises 08:50 - Optimizing Treatment: Dose, Duration, and Frequency 11:16 - Conclusion: The True Value of IV Vitamin C Sound Bites: “There’s still a debate about IV vitamin C.” “Vitamin C improves the quality of life.” “The greater cost is not including high-dose IV vitamin C in cancer care.” Why IV Vitamin C Matters: High-dose IV vitamin C is not just an alternative therapy—it’s a scientifically-backed treatment with profound implications for patient care. It enhances quality of life, augments conventional treatments, and offers a holistic approach to addressing cancer’s metabolic vulnerabilities. By leveraging its oxidative properties, this therapy empowers patients and practitioners to explore innovative, evidence-based solutions. Learn More: Check out the full episode and supporting references at pre-scribe.com. Listen to the Prescribed Podcast by Dr. Nathan Goodyear on Podbean or wherever you get your podcasts. Keywords: IV vitamin C, cancer care, integrative medicine, high dose vitamin C, chemotherapy, wellness, health, oxidative stress, treatment mechanisms, patient care Subscribe for your next dose of medical innovation, and let us know your thoughts in the comments! #IVVitaminC #CancerCare #IntegrativeMedicine #HighDoseVitaminC #DrNathanGoodyear #Wellness #OxidativeStress #PatientCare #Chemotherapy
    Show More Show Less
    12 mins
  • Can Breast Cancer Biopsies Trigger Spread? | Risks, Advanced Testing & Safer Options | Dr. Goodyear

    Can Breast Cancer Biopsies Trigger Spread? | Risks, Advanced Testing & Safer Options | Dr. Goodyear
    Dec 20 2024
    Dr. Nathan Goodyear dives deep into the latest in integrative cancer care. In this episode, we take a critical look at breast cancer biopsy methods, the associated survival rates, and the long-term impacts of different biopsy techniques on patient outcomes. For patients facing a breast cancer diagnosis, the type of biopsy selected—whether fine needle aspirate (FNA), core needle biopsy, or excisional biopsy—can significantly impact survival and long-term health. Key Topics Covered: Biopsy Methods and Survival Impact: Dr. Goodyear explores evidence from a major cohort study examining 3,416 breast cancer patients, discussing the survival implications based on biopsy type. He delves into the five-year survival rates associated with each method and the crucial role radiotherapy plays in modifying these outcomes. In particular, fine needle aspirate biopsies show a distinct survival advantage over core needle biopsies in terms of disease-free outcomes, making the biopsy type a critical decision in patient care. Risks of Distant Metastasis: Highlighting research from a Swedish study, Dr. Goodyear explains how core needle biopsies are linked to higher rates of metastasis in breast cancer patients 5 to 15 years after diagnosis. This segment provides insights into the lasting impact of biopsy methods on cancer spread, with core needle biopsies showing increased long-term risk. This critical information can empower patients to engage in informed discussions with their healthcare providers. The Role of Immunoediting in Cancer Progression: Immunoediting is a process by which the immune system manages cancer cells through phases of elimination, equilibrium, and escape. Dr. Goodyear discusses how invasive biopsy techniques may disrupt this natural process, shifting the cancer from a controlled state to one where it evades the immune system. This segment underscores the need for caution when selecting biopsy methods to avoid inadvertently advancing tumor growth. Advancements in Biopsy Techniques: Dr. Goodyear examines innovative techniques that are paving the way for less invasive, higher-precision approaches to cancer diagnosis. These include liquid biopsies—like Guardant360 and BostonGene—which analyze circulating tumor DNA and genetic fragments in the blood, potentially offering a safer alternative to traditional tissue biopsies. He also shares his experience with intratumoral immunotherapy, where biopsy, ablation, and immunotherapy are combined in one minimally invasive procedure to reduce risks and enhance patient outcomes. Patient Empowerment and Informed Decision-Making: In an era of advancing technologies, patients have more options than ever before. Dr. Goodyear advocates for patient empowerment through evidence-based decisions, encouraging individuals to question standard procedures and choose the biopsy method that aligns with their unique health goals. He also highlights the limitations of current protocols and urges patients to stay informed and proactive in their cancer care. Key Takeaways: Survival Rates Vary: Each biopsy type impacts survival differently, with excisional biopsies showing higher survival rates. Metastasis Risks Are Real: Core needle biopsies increase the risk of distant metastasis over time. Immunoediting Disruption: Certain biopsy techniques may interfere with the immune system’s ability to control cancer growth. Liquid Biopsies Hold Promise: Emerging technologies are transforming biopsy practices, potentially reducing the need for invasive procedures. Empower Yourself: Informed patients can advocate for safer, personalized cancer care decisions. Chapter Timestamps: 00:00 - Introduction: Why Biopsy Type Matters 02:55 - Comparing Fine Needle, Core Needle, and Excisional Biopsies 05:46 - The Role of Radiotherapy in Survival Rates 09:07 - Immunoediting and Cancer’s Progression 12:11 - Surgical Risks and Patient Empowerment 15:06 - Innovations in Biopsy Techniques: Liquid Biopsies and Beyond 17:58 - Moving Forward: Empowering Patients and Elevating Cancer Care For More Information: 📑 Visit our website at pre-scribed.com to read the full study references and show notes for this episode. Subscribe to Prescribed for your weekly dose of medical innovation, patient-centered insights, and cutting-edge cancer care approaches! 👉 Don’t forget to like, comment, and subscribe for more episodes on cancer treatment, patient empowerment, and medical advancements! #BreastCancer #BiopsyMethods #CancerSurvival #PatientEmpowerment #InnovativeMedicine #CancerTreatment #IntegrativeOncology #FineNeedleBiopsy #CoreNeedleBiopsy #LiquidBiopsies #DrNathanGoodyear #PrescribedPodcast
    Show More Show Less
    19 mins
  • Dr. Nathan Goodyear Returns: The Prescribed Podcast – Your Podcast For Integrative Cancer Care

    Dr. Nathan Goodyear Returns: The Prescribed Podcast – Your Podcast For Integrative Cancer Care
    Dec 20 2024
    Welcome to the relaunch of Dr. Nathan Goodyear's podcast, now reimagined as Prescribed by Dr. Nathan Goodyear. This channel is your go-to resource for insights into integrative medicine, holistic cancer care, and patient-centered health solutions. With a renewed purpose, Dr. Goodyear’s mission is to empower both patients and practitioners with the latest knowledge and best practices in healing. In this introductory episode, Dr. Goodyear shares the journey that led him from Practicing with Dr. Nathan Goodyear to Prescribed, detailing the experiences and values that shape his work today. Guided by principles of Hope, Heal, Teach, Serve, Trust, and Legacy, Dr. Goodyear is dedicated to delivering impactful knowledge, emphasizing the importance of innovation and the value of community in healthcare. 🎯 What This Episode Covers: Why Prescribed Was Created: Dr. Goodyear dives into the purpose behind the shift, detailing how he realigned his mission and what this new direction means for patients and practitioners. Core Values Driving the Podcast: Explore the principles of Hope, Heal, Teach, Serve, Trust, and Legacy, which form the foundation of Dr. Goodyear’s approach to patient care and professional growth. Innovations in Integrative Oncology: Gain insight into the latest advances in integrative cancer care, holistic therapies, and patient-centered treatment models that focus on quality of life and lasting health. Patient-First Healthcare Philosophy: Dr. Goodyear discusses the importance of breaking away from profit-centered approaches to focus on healing, teaching, and empowering patients. An Invitation to Engage and Empower: Whether you’re a patient seeking knowledge or a practitioner committed to better care, this podcast is here to empower, educate, and inspire you every step of the way. 💡 Why Subscribe to Prescribed by Dr. Nathan Goodyear? Prescribed is your source for integrative cancer care, guided by a physician who blends the latest research with compassionate care. Dr. Goodyear invites you to join a journey of learning, empowerment, and discovery. Each episode offers practical knowledge, whether it’s a deep dive into innovative therapies or a conversation on patient empowerment, all presented in a way that’s engaging and actionable. Expect episodes that cover trending health topics, breakthrough treatments, and conversations with leading experts. Subscribe for content that supports your health journey, expands your knowledge, and uplifts your perspective on holistic healing. 🔔 Subscribe & Enable Notifications Be sure to subscribe and turn on notifications so you never miss an episode! Dr. Goodyear’s weekly content offers a wealth of insights to help you make informed decisions on your journey toward health and wellness. 📌 Episode Timeline: [00:00] – Dr. Goodyear’s Return and New Mission [02:00] – The Transition from Practicing to Prescribed [04:30] – Key Values: Hope, Heal, Teach, Serve, Trust & Legacy [08:00] – How Integrative Medicine Elevates Patient Care [12:00] – Shifting Focus to Patient-First Care [16:30] – Innovations in Cancer Care [22:00] – Empowering Patients & Practitioners Alike [25:00] – Topics to Look Forward to in Future Episodes 🤝 Join the Conversation Dr. Goodyear values your input! Comment below with your thoughts, questions, or topic suggestions. Your feedback helps shape future episodes and strengthens our community of learners and health advocates. 🌐 Connect with Dr. Nathan Goodyear: Website: pre-scribed.com Key Takeaways: Purpose-Driven Care Dr. Goodyear highlights the values behind Prescribed, emphasizing patient-centered, purpose-driven healthcare. Insights into Cancer Care With years of expertise in integrative oncology, Dr. Goodyear offers practical insights to help both patients and practitioners navigate cancer treatment. Empowerment for All This podcast empowers listeners to take control of their health journey, informed by Dr. Goodyear’s knowledge and compassion. Building a Community of Health Seekers By subscribing, you join a supportive community focused on growth, learning, and meaningful health conversations. About Dr. Nathan Goodyear: Dr. Nathan Goodyear is an expert in integrative oncology, dedicated to patient-centered healing, transformative care, and empowering patients and practitioners alike. With a focus on compassionate care and evidence-based therapies, Dr. Goodyear’s mission is to inspire hope and foster a legacy of healing. Tags: Integrative Medicine, Cancer Care, Patient Empowerment, Holistic Healing, Dr. Nathan Goodyear, Prescribed Podcast, Integrative Oncology, Functional Medicine, Cancer Treatment, Health Podcast Thank you for joining Prescribed by Dr. Nathan Goodyear. Like, share, and subscribe if you find this content valuable. Together, let’s create a community dedicated to knowledge, compassion, and positive change in healthcare.
    Show More Show Less
    28 mins